Global agreement signed

Article

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Leica's ophthalmic portfolio will be available to B + L, ranging from routine cataract microscopes to high-end retinal systems and including the Leica M822 for cataract procedures which combines LED and halogen lighting for a stable red reflex.

Executive vice president and president of Bausch + Lomb, John Barr, stated, "We are happy to announce the partnership of two leading companies in the field of eye surgery. Bausch + Lomb is a perfect partner for companies, such as Leica Microsystems, looking to broaden their market reach through a powerful worldwide commercial infrastructure."

"Leica Microsystems is a trusted, established brand in the industry and the company is known for their innovative microscopes and scientific instruments," continued Mr Barr. "We are excited to offer Leica surgical microscopes, as they enhance our ability to offer a ‘one-stop shop’ for an ophthalmic surgeons’ needs, while also accelerating the growth of our business.”

Eoghan O'Lionaird, president of Leica Microsystems, commented, "Through this partnership with Bausch + Lomb, we will be able to provide more patients around the world with better access to our world-leading imaging systems. We are pleased to have such a respected and innovative company as Bausch + Lomb as our partner. Our customers, their patients, and our business will benefit from this collaboration as ophthalmic surgeons will have a single source supplier for their equipment needs."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.